NCT07294456

Brief Summary

This cross-sectional study aims to evaluate the periodontal status of individuals diagnosed with hidradenitis suppurativa (HS) and to compare them with systemically healthy controls. HS is a chronic inflammatory skin disease characterized by recurrent lesions and systemic inflammation, which may influence periodontal health. In this study, periodontal parameters-including probing depth, clinical attachment loss, gingival index, plaque index, and bleeding on probing-will be assessed using standard clinical methods. Dermatological examination will include disease duration, lesion characteristics, and Hurley staging. The study will investigate the prevalence of periodontitis in HS patients and explore potential associations between periodontal findings and HS severity. Findings from this research may provide insight into shared inflammatory pathways and contribute to understanding the possible link between HS and periodontal disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
226

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
Last Updated

December 29, 2025

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

December 8, 2025

Last Update Submit

December 20, 2025

Conditions

Keywords

HİDRADENİTİS SUPPURATİVAPERİODONTAL DİSEASEPERİODONTİTİSGİNGİVAL İNFLAMMATİON

Outcome Measures

Primary Outcomes (1)

  • Correlation Between Periodontal Status and Hidradenitis suppurativa

    Baseline (single assessment)

Secondary Outcomes (3)

  • Correlation between Periodontal Status and Hurley Stage

    Baeline (single assesment)

  • Corralation between Hurley Stage and Oral Health Impact Profile OHIP-14) Score

    baseline (single assesment)

  • Correlation between Dermatology Life Quality Index (DLQI) and Oral Health Impact Profile (OHIP-14) Total Score

    baseline (single assesment)

Study Arms (2)

Hidradenitis Suppurativa Group

Participants diagnosed with hidradenitis suppurativa undergoing periodontal examination.

Other: No intervention (observational study)

Healthy Control Group

Systemically healthy individuals without hidradenitis suppurativa undergoing periodontal examination.

Other: No intervention (observational study)

Interventions

Observational study with no treatment or intervention applied.

Healthy Control GroupHidradenitis Suppurativa Group

Eligibility Criteria

Age18 Minutes+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult individuals with a confirmed diagnosis of hidradenitis suppurativa and age-matched healthy controls, each having at least 12 teeth (excluding third molars), and no recent periodontal or systemic treatment.

You may qualify if:

  • Having a diagnosis of hidradenitis suppurativa.
  • Age greater than 18 years.
  • Presence of at least 12 teeth in the mouth, excluding third molars.

You may not qualify if:

  • Age under 18 years.
  • Pregnancy.
  • Breastfeeding.
  • Receiving treatment for periodontitis or hidradenitis suppurativa within the past 3 months.
  • Use of antibiotics, anti-inflammatory drugs, or immunomodulatory medications within the past 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences, Gülhane Faculty of Dentistry

Ankara, None Selected, 6220, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hidradenitis SuppurativaGingival DiseasesDry SocketGingivitis

Interventions

Observation

Condition Hierarchy (Ancestors)

Skin Diseases, BacterialBacterial InfectionsBacterial Infections and MycosesInfectionsSkin Diseases, InfectiousSuppurationSkin DiseasesSkin and Connective Tissue DiseasesHidradenitisSweat Gland DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ASSİSTANT PROFESSOR

Study Record Dates

First Submitted

December 8, 2025

First Posted

December 19, 2025

Study Start

June 1, 2025

Primary Completion

September 1, 2025

Study Completion

September 15, 2025

Last Updated

December 29, 2025

Record last verified: 2025-12

Locations